These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 24687338

  • 1. Clinical features and treatment outcomes of pediatric acute promyelocytic leukemia in a Mexican pediatric hospital.
    Dorantes-Acosta E, Medina-Sanson A, Jaimes-García Y, López-Martínez B.
    Rev Invest Clin; 2013; 65(5):392-8. PubMed ID: 24687338
    [Abstract] [Full Text] [Related]

  • 2. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N.
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [Abstract] [Full Text] [Related]

  • 3. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
    Park TS, Choi JR, Yoon SH, Song J, Kim J, Kim SJ, Kwon O, Min YH.
    Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
    [Abstract] [Full Text] [Related]

  • 4. All-transretinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia.
    Al Bahar S, Pandita R, Bavishi K, Kreze O.
    Indian J Cancer; 2004 Dec; 41(3):125-8. PubMed ID: 15472411
    [Abstract] [Full Text] [Related]

  • 5. Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia.
    Lou Y, Qian W, Meng H, Mai W, Tong H, Tong Y, Huang J, Jin J.
    Hematol Oncol; 2014 Mar; 32(1):40-6. PubMed ID: 23963734
    [Abstract] [Full Text] [Related]

  • 6. Management of acute promyelocytic leukemia relapse in the ATRA era.
    Castagnola C, Lunghi M, Corso A, Tajana M, Zappasodi P, Dabusti M, Lazzarino M, Bernasconi C.
    Haematologica; 1998 Aug; 83(8):714-7. PubMed ID: 9793255
    [Abstract] [Full Text] [Related]

  • 7. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
    Zubizarreta PA, Rose AB, Felice MS, Alfaro E, Delfino S, Cygler AM, Sackmann-Muriel F.
    Pediatr Hematol Oncol; 2000 Mar; 17(2):155-62. PubMed ID: 10734658
    [Abstract] [Full Text] [Related]

  • 8. Treatment of acute promyelocytic leukemia with PETHEMA LPA 99 protocol: a Tunisian single center experience.
    Jeddi R, Ghédira H, Menif S, Ben Neji H, Ben Amor R, Kacem K, Aissaoui L, Bouteraâ W, Abdennebi Y, Raihane BL, Gouider E, Raouf H, Hèla BA, Saad A, Zaher B, Meddeb B.
    Hematology; 2010 Aug; 15(4):204-9. PubMed ID: 20670478
    [Abstract] [Full Text] [Related]

  • 9. All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).
    Chim CS, Kwong YL, Liang R, Chu YC, Chan CH, Chan LC, Wong KF, Chan TK.
    Hematol Oncol; 1996 Sep; 14(3):147-54. PubMed ID: 9119359
    [Abstract] [Full Text] [Related]

  • 10. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].
    Xu XJ, Shi SW, Tang YM, Song H, Yang SL, Wei J, Xu WQ, Pan BH, Chen YH, Zhao FY, Shen HQ, Qian BQ, Zhang LY, Ning BT.
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):28-33. PubMed ID: 17306073
    [Abstract] [Full Text] [Related]

  • 11. Favourable outcome in an APL patient with PLZF/RARalpha fusion gene: quantitative real-time RT-PCR confirms molecular response.
    Cassinat B, Guillemot I, Moluçon-Chabrot C, Zassadowski F, Fenaux P, Tournilhac O, Chomienne C.
    Haematologica; 2006 Dec; 91(12 Suppl):ECR58. PubMed ID: 17194664
    [Abstract] [Full Text] [Related]

  • 12. Problems existing in differentiation therapy of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA).
    Wang ZY, Chen Z, Huang W, Li XS, Lu JX, Huang LA, Zhang FQ, Gu LJ, Ouyang RR, Chen SJ.
    Blood Cells; 1993 Dec; 19(3):633-41; discussion 642-7. PubMed ID: 8018944
    [Abstract] [Full Text] [Related]

  • 13. Treatment of acute promyelocytic leukemia: a single institution experience.
    Ruiz-Argüelles GJ, Morales-Toquero A, Gómez-Rangel JD, López-Martínez B, Ruiz-Delgado GJ, Reyes-Núñez V.
    Rev Invest Clin; 2005 Dec; 57(3):415-9. PubMed ID: 16187701
    [Abstract] [Full Text] [Related]

  • 14. [Preliminary results of a multicenter randomized study on the treatment of acute promyelocytic leukemias].
    Parovichnikova EN, Savchenko VG, Demidova IA, Isaev VG, Shuravina EN, Ustinova EN, Gribanova EO, Aleksanian MZh, Misiurin AV, Domracheva EV, Ol'shanskaia IuV, Khoroshko ND, Kravchenko SK, Konstantinova TS, Anchukova LV, Kaplanov K, Zagoskina TP, Volkova SA, Filatov LB, Rekhtman GB, Sokolova I, Mashuk VN, Miliutina GI, Lapin VA, Perekatova TN, Sviridova EI, Pristupa AS, Ziuzgin IS.
    Ter Arkh; 2004 Dec; 76(7):11-8. PubMed ID: 15379121
    [Abstract] [Full Text] [Related]

  • 15. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
    Rodríguez Gómez M, López Fernández MF, Batlle J.
    Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380
    [Abstract] [Full Text] [Related]

  • 16. [Effectiveness of trans-retinoic acid in the treatment of acute promyelocytic leukemia: initial results of a multicenter study].
    Parovichnikova EN, Savchenko VG, Kliasova GA, Isaev VG, Demidova IA, Ol'shanskaia IuV, Tiurina NG, Tikhonova LIu, Galstian GM, Pivnik AV.
    Ter Arkh; 1999 Dec; 71(7):20-4. PubMed ID: 10481862
    [Abstract] [Full Text] [Related]

  • 17. Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature.
    Betancourt-García RD, Castro J, Fernández AC, López-Enríquez A, Fradera J, Pacheco E.
    P R Health Sci J; 2009 Jun; 28(2):146-50. PubMed ID: 19530558
    [Abstract] [Full Text] [Related]

  • 18. Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy.
    Breccia M, Diverio D, Noguera NI, Visani G, Santoro A, Locatelli F, Damiani D, Marmont F, Vignetti M, Petti MC, Lo Coco F.
    Haematologica; 2004 Jan; 89(1):29-33. PubMed ID: 14754603
    [Abstract] [Full Text] [Related]

  • 19. Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention.
    Esteve J, Escoda L, Martín G, Rubio V, Díaz-Mediavilla J, González M, Rivas C, Alvarez C, González San Miguel JD, Brunet S, Tomás JF, Tormo M, Sayas MJ, Sánchez Godoy P, Colomer D, Bolufer P, Sanz MA, Spanish Cooperative Group PETHEMA.
    Leukemia; 2007 Mar; 21(3):446-52. PubMed ID: 17205057
    [Abstract] [Full Text] [Related]

  • 20. Pediatric acute promyelocytic leukemia: all-transretinoic acid therapy in a Brazilian pediatric hospital.
    da Costa Moraes CA, Trompieri NM, Cavalcante Felix FH.
    J Pediatr Hematol Oncol; 2008 May; 30(5):387-90. PubMed ID: 18458575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.